Genemod
PrivateLast Round
Seed
May 4, 2023
Total Funding Raised
$6.2M
Company Overview
Genemod operates in Healthcare & Life Sciences and is based in Edmonds, Washington. Its latest recorded funding round was a Seed round in May 2023.
Genemod is a biotechnology software company that provides a cloud-based laboratory management platform for life science research and development teams.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Vertical SaaS, Workflow Automation, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genemod Comparables
Compare Genemod with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Labii Inc. | 90% | |
| Scispot | 90% | |
| Labric | 86% |
For institutional investors. Book with your work email.
Genemod Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genemod Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Seed |
| Defy Partners Management | Seed |
| Canaan Partners | Seed |
| LDV Partners | Seed |
| Cercano Management | Seed |
| Unpopular Ventures | Seed |
| Underdog Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 8, 2026
Added Niedenthal Emotions Lab as a customer.
- Dec 8, 2025
Genemod, Inc. has integrated with Third Wave Analytics, Inc. The partnership was announced in the article's title, but the article body provides no further details.
For institutional investors. Book with your work email.
Genemod Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genemod's valuation, stock price, and market status.
Is Genemod a public or private company?
Genemod is a private company.
What is the current stock price of Genemod?
Genemod is a private company, so its shares have no public market price. Caplight tracks Genemod's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genemod worth (valuation)?
Valuation information for Genemod is not publicly available.
Can I buy Genemod stock?
Genemod shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genemod's last funding round?
Genemod's most recent funding round was Seed on May 4, 2023.
Who are the main investors in Genemod?
Key investors in Genemod include Defy Partners Management, LDV Partners.
Will Genemod IPO soon?
No public IPO plans have been announced for Genemod.
How can I track Genemod secondary market activity?
Caplight tracks bids, offers, and trades in Genemod's shares on secondary markets.